Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Zimmermann

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Translational Oncology|October 27, 2015
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR MethodologyEser Kirkizlar, Bernhard Zimmermann, Tudor Constantin, et al.
American Journal of Obstetrics and Gynecology|August 12, 2014
Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testingPe'er Dar, Kirsten J Curnow, Susan J Gross, et al.
Obstetrics and Gynecology|July 9, 2014
Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohortEugene Pergament, Howard Cuckle, Bernhard Zimmermann, et al.
Neurophotonics|April 9, 2025
Co-localized optode-electrode design for multimodal functional near infrared spectroscopy and electroencephalographyDe'Ja Rogers, Walker Joseph O'Brien, Yuanyuan Gao, et al.
American Journal of Obstetrics and Gynecology|December 6, 2014
Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromesRonald J Wapner, Joshua E Babiarz, Brynn Levy, et al.
NPJ Breast Cancer|March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence riskMark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
Journal of Clinical Medicine|December 26, 2018
Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCRTara K Sigdel, Felipe Acosta Archila, Tudor Constantin, et al.
Obstetrics and Gynecology|November 26, 2024
Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. CohortMarisa Gilstrop Thompson, Wenbo Xu, Bridget Moore, et al.
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.
Nature Cancer|February 5, 2022
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumabScott V Bratman, S Y Cindy Yang, Marco A J Iafolla, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Translational Oncology|October 27, 2015
Detection of Clonal and Subclonal Copy-Number Variants in Cell-Free DNA from Patients with Breast Cancer Using a Massively Multiplexed PCR MethodologyEser Kirkizlar, Bernhard Zimmermann, Tudor Constantin, et al.
American Journal of Obstetrics and Gynecology|August 12, 2014
Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testingPe'er Dar, Kirsten J Curnow, Susan J Gross, et al.
Obstetrics and Gynecology|July 9, 2014
Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohortEugene Pergament, Howard Cuckle, Bernhard Zimmermann, et al.
Neurophotonics|April 9, 2025
Co-localized optode-electrode design for multimodal functional near infrared spectroscopy and electroencephalographyDe'Ja Rogers, Walker Joseph O'Brien, Yuanyuan Gao, et al.
American Journal of Obstetrics and Gynecology|December 6, 2014
Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromesRonald J Wapner, Joshua E Babiarz, Brynn Levy, et al.
NPJ Breast Cancer|March 26, 2021
Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence riskMark Jesus M Magbanua, Wen Li, Denise M Wolf, et al.
Journal of Clinical Medicine|December 26, 2018
Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCRTara K Sigdel, Felipe Acosta Archila, Tudor Constantin, et al.
Obstetrics and Gynecology|November 26, 2024
Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. CohortMarisa Gilstrop Thompson, Wenbo Xu, Bridget Moore, et al.
Gynecologic Oncology|September 18, 2022
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancerJune Y Hou, Jocelyn S Chapman, Ekaterina Kalashnikova, et al.
Nature Cancer|February 5, 2022
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumabScott V Bratman, S Y Cindy Yang, Marco A J Iafolla, et al.
Pageof 5